{"id":"NCT00713817","sponsor":"Jazz Pharmaceuticals","briefTitle":"A Study to Determine the Maintenance of Effect After Long-term Treatment of Sativex速 in Subjects With Neuropathic Pain","officialTitle":"A Multicentre, Open Label, Follow on Study to Assess the Maintenance of Effect, Tolerance and Safety of Sativex速 in the Treatment of Subjects With Neuropathic Pain. This Will be Followed by a Randomised-withdrawal Phase (Part B) for a Subset of Patients","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-03","primaryCompletion":"2007-07","completion":"2007-07","firstPosted":"2008-07-11","resultsPosted":"2012-08-16","lastUpdate":"2023-05-03"},"enrollment":19,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"SUPPORTIVE_CARE"},"conditions":["Pain","Peripheral Neuropathy"],"interventions":[{"type":"DRUG","name":"Sativex速","otherNames":["GW-1000-02"]},{"type":"DRUG","name":"Placebo","otherNames":["GW-4001-01"]}],"arms":[{"label":"Sativex","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to assess the maintenance of effect after long-term treatment of Sativex速 in subjects with neuropathic pain.","primaryOutcome":{"measure":"Change From Baseline in Mean Daily Pain Severity on a 0-10 Numerical Rating Scale Score at the End of Treatment (Average of Last 7 Days Treatment)","timeFrame":"Day 0-35","effectByArm":[{"arm":"Sativex","deltaMin":0.57,"sd":1.06},{"arm":"Placebo","deltaMin":-0.49,"sd":2.32}],"pValues":[{"comp":"OG000 vs OG001","p":"0.273"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":1},"locations":{"siteCount":1,"countries":["United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":10},"commonTop":["Headache","Tremor","Hyperhidrosis","Fatigue","Insomnia"]}}